New drug targets hidden pain after keyhole surgery
NCT ID NCT07246785
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called anrikefon for treating deep internal pain after laparoscopic (keyhole) surgery. It was given through a pump that patients could control. The trial was stopped early and included only 13 adults. The goal was to see if anrikefon could better manage this type of pain compared to standard treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANRIKEFON are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new mesh implant fix pelvic organ prolapse better?
- New opioid aims to cut Post-Surgery nausea without sacrificing pain relief
- New monitoring method may keep seniors breathing easier after surgery
- Scientists test best way to combine two common anesthetics
- Could a simple injection before surgery cut Post-Op pain?
- New study aims to cut Post-Surgery pain by sucking out trapped gas